摘要 |
The present invention relates to novel process for preparing ophthalmic pharmaceutical compositions comprising an inflammation-treating amount of a 4-aminoquinoline compound, derivative, isomers, or chemical salts, compositions resulting therefrom and methods for using these compositions for the treatment of ocular inflammatory conditions by topical administration directly to the eye. |